Topic-Contributed Paper Session
Targeted Validation, Broader Benefit: Advancing Public Health with Two-Phase Designs
Sarah LotspeichOrganizerLucy D'Agostino McGowanChair
Biometrics Section co: Section on Statistics in Epidemiologyco: ENAR Applied
About this session
This session highlights recent innovations in two-phase studies, especially extreme-tail and related targeted sampling strategies, to emphasize how design choices yield broader public health benefits. Our speakers will showcase diverse applications: reducing bias in community-level food access metrics, extending causal inference to new populations despite incomplete covariate overlap, balancing efficiency across multiple models in pharmaceutical and observational studies, and improving cost-effective evaluation of cancer screening tests. Collectively, these talks demonstrate how modern applications and extensions of extreme tail sampling and two-phase designs advance beyond traditional paradigms to meet the needs of complex health research. In line with the JSM theme, Communities in Action: Advancing Society, the session underscores how innovations in extreme-tail and targeted two-phase sampling can generate more accurate, equitable, and actionable insights for the communities we aim to serve.
5 Presentations
10:35 AM - 10:55 AM
Weidong Ma (Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine)
10:55 AM - 11:15 AM
Sarah Lotspeich (Wake Forest University)
11:15 AM - 11:35 AM
Co-authors: Richard Cook (University of Waterloo), Thomas Lorey (Kaiser Permanente Northern California), Nicolas Wentzensen (National Cancer Institute), Li Cheung (National Cancer Institute)
11:35 AM - 11:55 AM
Cole Manschot (Merck)